AUSTIN, Texas, Sept. 9 /PRNewswire-FirstCall/ — Luminex
Corporation (Nasdaq:
LMNX) today announced that management will present at UBS
Global Life Sciences Conference to be held September 20 – 22, 2010,
in New York City, New York.
(Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO)
(Logo: http://www.newscom.com/cgi-bin/prnh/20100104/LUMINEXLOGO)
The investor presentation by Patrick J. Balthrop, president and
chief executive officer, will begin at 8:00 a.m. Eastern time on
Wednesday, September 22, 2010. The presentation will be
webcast live and may be accessed at Luminex Corporation’s website
at http://www.luminexcorp.com.
Simply log on to the web at the address above, go to the
Company section and access the Investor Relations link.
Please go to the website at least 15 minutes prior to the
event to register, download and install any necessary audio/video
software. If you are unable to participate during the live webcast,
the presentation will be archived for six months on the website
using the ‘replay’ link.
About Luminex Corporation Luminex Corporation develops,
manufactures and markets proprietary biological testing
technologies with applications throughout the diagnostic and life
sciences industries. The Company’s xMAP(R) multiplex solutions
include an open-architecture, multi-analyte technology platform
that delivers fast, accurate and cost-effective bioassay results to
markets as diverse as pharmaceutical drug discovery, clinical
diagnostics and biomedical research, including the genomics and
proteomics markets. The Company’s xMAP Technology is sold worldwide
and is already in use in leading clinical laboratories as well
a
‘/>”/>
SOURCE
